CPHI logo

China Pharma Holdings (CPHI) Free Cash Flow

Annual FCF

-$711.20 K
+$100.30 K+12.36%

31 December 2023

CPHI Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

-$37.70 K
+$63.10 K+62.60%

30 September 2024

CPHI Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

-$750.50 K
-$1.04 M-361.04%

30 September 2024

CPHI TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CPHI Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.4%-103.8%-936.6%
3 y3 years+21.8%+95.7%-986.1%
5 y5 years-138.8%-108.1%-153.6%

CPHI Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-3.4%+21.8%-103.8%+97.4%-361.0%+69.5%
5 y5 years-138.8%+21.8%-103.8%+97.4%-153.6%+69.5%
alltimeall time-126.3%+93.2%-100.5%+99.5%-112.2%+94.0%

China Pharma Holdings Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
-$37.70 K(-62.6%)
-$750.50 K(-361.0%)
June 2024
-
-$100.80 K(-82.8%)
$287.50 K(+67.2%)
Mar 2024
-
-$585.20 K(+2083.6%)
$171.90 K(-124.2%)
Dec 2023
-$711.20 K(-12.4%)
-$26.80 K(-102.7%)
-$711.10 K(+882.2%)
Sept 2023
-
$1.00 M(-562.2%)
-$72.40 K(-93.5%)
June 2023
-
-$216.40 K(-85.3%)
-$1.11 M(-20.9%)
Mar 2023
-
-$1.47 M(-339.9%)
-$1.40 M(+72.4%)
Dec 2022
-$811.50 K(+18.0%)
$611.90 K(-1932.0%)
-$811.40 K(-50.2%)
Sept 2022
-
-$33.40 K(-93.4%)
-$1.63 M(-33.9%)
June 2022
-
-$509.10 K(-42.2%)
-$2.46 M(+90.6%)
Mar 2022
-
-$880.80 K(+329.2%)
-$1.29 M(+87.8%)
Dec 2021
-$687.90 K(-24.4%)
-$205.20 K(-76.3%)
-$687.90 K(-912.2%)
Sept 2021
-
-$866.80 K(-231.1%)
$84.70 K(-81.9%)
June 2021
-
$661.00 K(-338.7%)
$467.70 K(-178.7%)
Mar 2021
-
-$276.90 K(-148.8%)
-$594.50 K(-34.6%)
Dec 2020
-$909.60 K(-292.6%)
$567.40 K(-217.3%)
-$909.60 K(-41.3%)
Sept 2020
-
-$483.80 K(+20.6%)
-$1.55 M(+159.3%)
June 2020
-
-$401.20 K(-32.2%)
-$597.60 K(-413.5%)
Mar 2020
-
-$592.00 K(+717.7%)
$190.60 K(-59.6%)
Dec 2019
$472.30 K(-74.2%)
-$72.40 K(-115.5%)
$472.30 K(-66.3%)
Sept 2019
-
$468.00 K(+20.9%)
$1.40 M(-22.7%)
June 2019
-
$387.00 K(-224.7%)
$1.81 M(+81.2%)
Mar 2019
-
-$310.30 K(-136.2%)
$1.00 M(-45.4%)
Dec 2018
$1.83 M(+159.8%)
$856.60 K(-2.6%)
$1.83 M(-0.6%)
Sept 2018
-
$879.90 K(-306.7%)
$1.84 M(+13.4%)
June 2018
-
-$425.70 K(-181.8%)
$1.62 M(+30.8%)
Mar 2018
-
$520.10 K(-40.1%)
$1.24 M(+76.2%)
Dec 2017
$704.70 K(-73.9%)
$867.60 K(+31.0%)
$704.70 K(-41.5%)
Sept 2017
-
$662.50 K(-181.9%)
$1.20 M(-13.3%)
June 2017
-
-$808.50 K(+4684.0%)
$1.39 M(-2.3%)
Mar 2017
-
-$16.90 K(-101.2%)
$1.42 M(-47.4%)
Dec 2016
$2.70 M(+162.2%)
$1.37 M(+61.4%)
$2.70 M(+33.5%)
Sept 2016
-
$846.70 K(-209.2%)
$2.02 M(-12.0%)
June 2016
-
-$775.30 K(-161.3%)
$2.30 M(-1.9%)
Mar 2016
-
$1.26 M(+83.5%)
$2.34 M(+127.4%)
Dec 2015
$1.03 M(-181.1%)
$688.90 K(-38.6%)
$1.03 M(-24.0%)
Sept 2015
-
$1.12 M(-253.5%)
$1.36 M(+1634.9%)
June 2015
-
-$731.20 K(+1383.2%)
$78.20 K(-235.8%)
Mar 2015
-
-$49.30 K(-104.9%)
-$57.60 K(-95.5%)
Dec 2014
-$1.27 M(-87.9%)
$1.01 M(-749.7%)
-$1.27 M(-81.1%)
Sept 2014
-
-$156.20 K(-82.0%)
-$6.72 M(-39.3%)
June 2014
-
-$867.00 K(-31.3%)
-$11.06 M(-11.2%)
Mar 2014
-
-$1.26 M(-71.5%)
-$12.46 M(+18.7%)
Dec 2013
-$10.50 M(+681.2%)
-$4.43 M(-1.6%)
-$10.50 M(+31.1%)
Sept 2013
-
-$4.50 M(+98.5%)
-$8.00 M(+131.1%)
June 2013
-
-$2.27 M(-422.3%)
-$3.46 M(+1320.9%)
Mar 2013
-
$703.40 K(-136.3%)
-$243.80 K(-81.9%)
DateAnnualQuarterlyTTM
Dec 2012
-$1.34 M(+338.6%)
-$1.94 M(-5122.5%)
-$1.34 M(+165.2%)
Sept 2012
-
$38.60 K(-95.9%)
-$506.70 K(-27.6%)
June 2012
-
$952.90 K(-340.3%)
-$699.50 K(-40.7%)
Mar 2012
-
-$396.60 K(-64.0%)
-$1.18 M(+285.1%)
Dec 2011
-$306.40 K(-88.8%)
-$1.10 M(+614.4%)
-$306.50 K(-64.0%)
Sept 2011
-
-$154.20 K(-132.7%)
-$850.60 K(+899.5%)
June 2011
-
$472.20 K(-1.0%)
-$85.10 K(-89.6%)
Mar 2011
-
$477.10 K(-129.0%)
-$822.00 K(-69.9%)
Dec 2010
-$2.73 M(-41.8%)
-$1.65 M(-369.2%)
-$2.73 M(+99.7%)
Sept 2010
-
$611.30 K(-330.9%)
-$1.37 M(-80.2%)
June 2010
-
-$264.70 K(-81.5%)
-$6.91 M(+2.8%)
Mar 2010
-
-$1.43 M(+410.0%)
-$6.72 M(+43.2%)
Dec 2009
-$4.69 M(+20.4%)
-$281.10 K(-94.3%)
-$4.69 M(-60.2%)
Sept 2009
-
-$4.93 M(+6618.0%)
-$11.78 M(-5496.6%)
June 2009
-
-$73.40 K(-112.4%)
$218.30 K(-108.8%)
Mar 2009
-
$593.70 K(-108.1%)
-$2.48 M(-36.3%)
Dec 2008
-$3.90 M(+1980.0%)
-$7.37 M(-204.3%)
-$3.90 M(-163.1%)
Sept 2008
-
$7.07 M(-354.9%)
$6.17 M(-451.9%)
June 2008
-
-$2.77 M(+237.2%)
-$1.75 M(-541.1%)
Mar 2008
-
-$822.60 K(-130.5%)
$397.70 K(-312.2%)
Dec 2007
-$187.40 K(-90.3%)
$2.70 M(-414.5%)
-$187.40 K(-92.3%)
Sept 2007
-
-$858.80 K(+38.2%)
-$2.42 M(-35.2%)
June 2007
-
-$621.50 K(-55.8%)
-$3.74 M(+30.8%)
Mar 2007
-
-$1.41 M(-402.9%)
-$2.86 M(+48.3%)
Dec 2006
-$1.93 M(+106.6%)
$464.80 K(-121.4%)
-$1.93 M(-19.4%)
Sept 2006
-
-$2.17 M(-942.0%)
-$2.39 M(+879.6%)
June 2006
-
$258.30 K(-154.2%)
-$244.30 K(-65.2%)
Mar 2006
-
-$476.40 K(+1718.3%)
-$702.70 K(+210.5%)
Dec 2005
-$933.20 K(+366.4%)
-
-
Sept 2005
-
-$26.20 K(-86.9%)
-$226.30 K(+13.1%)
June 2005
-
-$200.10 K(<-9900.0%)
-$200.10 K(<-9900.0%)
June 2005
-$200.10 K(+458.9%)
-
-
Mar 2005
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2004
-
$0.00(0.0%)
$0.00(-100.0%)
Sept 2004
-
$0.00(0.0%)
-$300.00(-99.2%)
June 2004
-$35.80 K(-61.5%)
$0.00(0.0%)
-$35.80 K(+59.1%)
Mar 2004
-
$0.00(-100.0%)
-$22.50 K(-79.5%)
Dec 2003
-
-$300.00(-99.2%)
-$109.90 K(-34.9%)
Sept 2003
-
-$35.50 K(-366.9%)
-$168.90 K(+81.4%)
June 2003
-$93.10 K(-68.9%)
$13.30 K(-115.2%)
-$93.10 K(-63.7%)
Mar 2003
-
-$87.40 K(+47.4%)
-$256.60 K(+58.6%)
Dec 2002
-
-$59.30 K(-247.1%)
-$161.80 K(+7.2%)
Sept 2002
-
$40.30 K(-126.8%)
-$151.00 K(-49.5%)
June 2002
-$299.20 K
-$150.20 K(-2129.7%)
-$299.10 K(+100.9%)
Mar 2002
-
$7400.00(-115.3%)
-$148.90 K(-4.7%)
Dec 2001
-
-$48.50 K(-55.0%)
-$156.30 K(+45.0%)
Sept 2001
-
-$107.80 K
-$107.80 K

FAQ

  • What is China Pharma Holdings annual free cash flow?
  • What is the all time high annual FCF for China Pharma Holdings?
  • What is China Pharma Holdings annual FCF year-on-year change?
  • What is China Pharma Holdings quarterly free cash flow?
  • What is the all time high quarterly FCF for China Pharma Holdings?
  • What is China Pharma Holdings quarterly FCF year-on-year change?
  • What is China Pharma Holdings TTM free cash flow?
  • What is the all time high TTM FCF for China Pharma Holdings?
  • What is China Pharma Holdings TTM FCF year-on-year change?

What is China Pharma Holdings annual free cash flow?

The current annual FCF of CPHI is -$711.20 K

What is the all time high annual FCF for China Pharma Holdings?

China Pharma Holdings all-time high annual free cash flow is $2.70 M

What is China Pharma Holdings annual FCF year-on-year change?

Over the past year, CPHI annual free cash flow has changed by +$100.30 K (+12.36%)

What is China Pharma Holdings quarterly free cash flow?

The current quarterly FCF of CPHI is -$37.70 K

What is the all time high quarterly FCF for China Pharma Holdings?

China Pharma Holdings all-time high quarterly free cash flow is $7.07 M

What is China Pharma Holdings quarterly FCF year-on-year change?

Over the past year, CPHI quarterly free cash flow has changed by -$1.04 M (-103.77%)

What is China Pharma Holdings TTM free cash flow?

The current TTM FCF of CPHI is -$750.50 K

What is the all time high TTM FCF for China Pharma Holdings?

China Pharma Holdings all-time high TTM free cash flow is $6.17 M

What is China Pharma Holdings TTM FCF year-on-year change?

Over the past year, CPHI TTM free cash flow has changed by -$678.10 K (-936.60%)